Taken together, these findings suggest that adipolin can ameliorate adverse cardiac remodeling following MI, at least in part, by its ability to reduce cardiomyocyte apoptosis through the Akt-dependent mechanism. This evidence concerns the gene AKT1 and myocardial infarction.